[Myoclonus and epilepsies in children]

Area of Science:

• Neurology
• Pediatrics
• Epileptology

Context:

• Myoclonic phenomena, encephalopathies, and epilepsy frequently co-occur, particularly in childhood.
• Existing classifications may not fully capture the spectrum of these associated conditions.
• Accurate differentiation is crucial for appropriate diagnosis and management.

Purpose:

• To review and categorize the associations between myoclonic phenomena, encephalopathies, and epileptic phenomena in children.
• To establish a framework for understanding five distinct groups of these conditions.
• To highlight key features, differential diagnoses, and prognostic implications for each group.

Summary:

• The study proposes a five-group classification: (1) myoclonus without encephalopathy/epilepsy, (2) encephalopathies with non-epileptic myoclonus (e.g., Kinsbourne syndrome, Hyperekplexia), (3) progressive encephalopathies with myoclonic seizures (Progressive Myoclonus Epilepsies), (4) epileptic encephalopathies with myoclonic seizures (e.g., West syndrome, Lennox-Gastaut syndrome), and (5) true myoclonic epilepsies (idiopathic vs. cryptogenic).
• Physiological myoclonus, benign sleep myoclonus, and benign myoclonus of early infancy are described in group 1.
• Progressive Myoclonus Epilepsies are emphasized as a subset of progressive encephalopathies, with discussion of major and rare causes.

Impact:

• Provides a structured approach to understanding complex pediatric neurological disorders.
• Aids clinicians in differential diagnosis, particularly for challenging cases involving myoclonus and epilepsy.
• Enhances the understanding of the relationship between epileptic activity and neurodevelopmental outcomes.